News
Professional-guided online cancer communities improve well-being, quality of life and reduce emotional distress and the risk of hospitalizations
Digital transformation and online resources are changing the relationship between healthcare professionals and their patients, and the way medical care is provided. The change from a traditional paternalistic model of medical care to a relational one, focused on the needs of patients and their families, promotes the empowerment of the user, responsibility for their illness, […]
Researchers from the IDIBELL and the University of Barcelona describe a new treatment that could cope with two bone diseases
The study describes the ability of a PI3-kinase inhibitor to combat Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva in murine preclinical models
EXTENDED DEADLINE — Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine
1.- Background The Centre for Regenerative Medicine of Barcelona (CMR[B]), together with the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Government(1), have launched the Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia – P-CMR[C]. The fundamental mission of the P-CMR[C] is to advance the implementation of regenerative medicine strategies by conducting research […]
Researchers from IDIBELL confirm the validity of xenographic models for studies of methylation and chemoresistance in breast cancer
The new study identifies patterns of DNA methylation associated with breast cancer subtypes and response to docetaxel using PDX models
An inflammatory diet correlates with colorectal cancer risk
The risk of developing colorectal cancer for individuals that follow a pro-inflammatory diet is two times higher than usual
Scientists Determine a mechanism that would allow treating more aggressive tumors
The study has proven the viability of this approach by studying in mice the evolution of metastatic colon tumors of human patients
Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels
The mechanism does not activate the reduction of oxygen in the cells of the tumor, contrary to what common drugs, called anti-angiogenic, usually cause
Quantum technology and cancer. Research and application in its detection and treatment
The Centre de Cultura Contemporània of Barcelona (CCCB), with the collaboration of the Bellvitge Biomedical Research Institute (IDIBELL) and the program of Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), organized last 25th June 2019 a conference at the CCCB called “Quantum Technology and Cancer. Research and application in its detection and treatment.” In this interactive […]
Brain structure determines individual differences regarding music sensitivity
The white matter structure in the brain reflects music sensitivity, according to a study by the research group on Cognition and Brain Plasticity of the Institute of Neurosciences of the University of Barcelona (UB) and the Bellvitge Biomedical Research Institute (UB-IDIBELL). The study, published in Journal of Neuroscience, shows that white matter connectivity, the tissue […]